The solution structure of the N-terminal domain of human vitronectin - Proximal sites that regulate fibrinolysis and cell migration

被引:35
作者
Mayasundari, A
Whittemore, NA
Serpersu, EH
Peterson, CB
机构
[1] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA
[2] Univ Tennessee, Ctr Excellence Struct Biol, Knoxville, TN 37996 USA
关键词
D O I
10.1074/jbc.M401279200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The three-dimensional structure of an N-terminal fragment comprising the first 51 amino acids from human plasma vitronectin, the somatomedin B (SMB) domain, has been determined by two-dimensional NMR approaches. An average structure was calculated, representing the overall fold from a set of 20 minimized structures. The core residues (18-41) overlay with a root mean square deviation of 2.29 +/- 0.62 Angstrom. The N- and C-terminal segments exhibit higher root mean square deviations, reflecting more flexibility in solution and/or fewer long-range NOEs for these regions. Residues 26-30 form a unique single-turn alpha-helix, the locus where plasminogen activator inhibitor type-1 (PAI-1) is bound. This structure of this helix is highly homologous with that of a recombinant SMB domain solved in a co-crystal with PAI-1 (Zhou, A., Huntington, J. A., Pannu, N. S., Carrell, R. W., and Read, R. J. (2003) Nat. Struct. Biol. 10, 541-544), although the remainder of the structure differs. Significantly, the pattern of disulfide cross-links observed in this material isolated from human plasma is altogether different from the disulfides proposed for recombinant forms. The NMR structure reveals the relative orientation of binding sites for cell surface receptors, including an integrin-binding site at residues 45 47, which was disordered and did not diffract in the co-crystal, and a site for the urokinase receptor, which overlaps with the PAI-1-binding site.
引用
收藏
页码:29359 / 29366
页数:8
相关论文
共 65 条
[1]   Vitronectin in human breast carcinomas [J].
Aaboe, M ;
Offersen, BV ;
Christensen, A ;
Andreasen, PA .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2003, 1638 (01) :72-82
[2]   SOLUTION STRUCTURE OF KISTRIN, A POTENT PLATELET-AGGREGATION INHIBITOR AND GP-IIB-IIIA ANTAGONIST [J].
ADLER, M ;
LAZARUS, RA ;
DENNIS, MS ;
WAGNER, G .
SCIENCE, 1991, 253 (5018) :445-448
[3]   The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin:: Implications for antiangiogenic strategies [J].
Bajou, K ;
Masson, V ;
Gerard, RD ;
Schmitt, PM ;
Albert, V ;
Praus, M ;
Lund, LR ;
Frandsen, TL ;
Brunner, N ;
Dano, K ;
Fusenig, NE ;
Weidle, U ;
Carmeliet, G ;
Loskutoff, D ;
Collen, D ;
Carmeliet, P ;
Foidart, JM ;
Noël, AS .
JOURNAL OF CELL BIOLOGY, 2001, 152 (04) :777-784
[4]   The biologic action of single-chain choriogonadotropin is not dependent on the individual disulfide bonds of the beta subunit [J].
BenMenahem, D ;
Kudo, M ;
Pixley, MB ;
Sato, A ;
Suganuma, N ;
Perlas, E ;
Hsueh, AJW ;
Boime, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (11) :6827-6830
[5]   Human ovarian adenocarcinoma cells synthesize vitronectin and use it to organize their adhesion [J].
Carreiras, F ;
Cruet, S ;
Staedel, C ;
Sichel, F ;
Gauduchon, P .
GYNECOLOGIC ONCOLOGY, 1999, 72 (03) :312-322
[6]  
Carriero MV, 1999, CANCER RES, V59, P5307
[7]   αv integrin, p38 mitogen-activated protein kinase, and urokinase plasminogen activator are functionally linked in invasive breast cancer cells. [J].
Chen, J ;
Baskerville, C ;
Han, QW ;
Pan, ZXK ;
Huang, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (51) :47901-47905
[8]   3-DIMENSIONAL SOLUTION STRUCTURE OF ESCHERICHIA-COLI PERIPLASMIC CYCLOPHILIN [J].
CLUBB, RT ;
FERGUSON, SB ;
WALSH, CT ;
WAGNER, G .
BIOCHEMISTRY, 1994, 33 (10) :2761-2772
[9]   Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin - Characterization of different PAI-1 mutants [J].
De Prada, NA ;
Schroeck, F ;
Sinner, EK ;
Muehlenweg, B ;
Twellmeyer, J ;
Sperl, S ;
Wilhelm, OG ;
Schmitt, M ;
Magdolen, V .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (01) :184-192
[10]   Structural and functional analysis of the plasminogen activator inhibitor-1 binding motif in the somatomedin B domain of vitronectin [J].
Deng, G ;
Royle, G ;
Wang, S ;
Crain, K ;
Loskutoff, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12716-12723